Composite polymer-bioceramic scaffolds with drug delivery capability for bone tissue engineering
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Next-generation scaffolds for bone tissue engineering (BTE) should exhibit the appropriate combination of mechanical support and morphological guidance for cell proliferation and attachment while at the same time serving as matrices for sustained delivery of therapeutic drugs and/or biomolecular signals, such as growth factors. Drug delivery from BTE scaffolds to induce the formation of functional tissues, which may need to vary temporally and spatially, represents a versatile approach to manipulating the local environment for directing cell function and/or to treat common bone diseases or local infection. In addition, drug delivery from BTE is proposed to either increase the expression of tissue inductive factors or to block the expression of others factors that could inhibit bone tissue formation. Composite scaffolds which combine biopolymers and bioactive ceramics in mechanically competent 3D structures, including also organic-inorganic hybrids, are being widely developed for BTE, where the affinity and interaction between biomaterials and therapeutic drugs or biomolecular signals play a decisive role in controlling the release rate. AREAS COVERED: This review covers current developments and applications of 3D composite scaffolds for BTE which exhibit the added capability of controlled delivery of therapeutic drugs or growth factors. A summary of drugs and biomolecules incorporated in composite scaffolds and approaches developed to combine biopolymers and bioceramics in composites for drug delivery systems for BTE is presented. Special attention is given to identify the main challenges and unmet needs of current designs and technologies for developing such multifunctional 3D composite scaffolds for BTE. EXPERT OPINION: One of the major challenges for developing composite scaffolds for BTE is the incorporation of a drug delivery function of sufficient complexity to be able to induce the release patterns that may be necessary for effective osseointegration, vascularization and bone regeneration. Loading 3D scaffolds with different biomolecular agents should produce a codelivery system with different, predetermined release profiles. It is also envisaged that the number of relevant bioactive agents that can be loaded onto scaffolds will be increased, whilst the composite scaffold design should exploit synergistically the different degradation profiles of the organic and inorganic components.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hydrogels for biomedical applications
Hoffman, A. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00239-3 · Cited by 4,864
Polymer blends and composites from renewable resources
Yu, L., Dean, K., & Li, L. (2006) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2006.03.002 · Cited by 2,107
Wei, G., & Ma, P. X. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.12.005 · Cited by 1,271
Reducing implant-related infections: active release strategies
Hetrick, E. M., & Schoenfisch, M. H. (2006) · Chemical Society Reviews · doi:10.1039/b515219b · Cited by 1,201
Antibiotic-eluting medical devices for various applications
ZILBERMAN, M., & ELSNER, J. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.020 · Cited by 610
Bioinorganics and biomaterials: Bone repair
Habibovic, P., & Barralet, J. E. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.03.027 · Cited by 441
Bone tissue engineering: from bench to bedside
Woodruff, M. A., Lange, C., Reichert, J., Berner, A., Chen, F., Fratzl, P., Schantz, J.-T., & Hutmacher, D. W. (2012) · Materials Today · doi:10.1016/s1369-7021(12)70194-3 · Cited by 182
Ovsianikov, A., Mironov, V., Stampfl, J., & Liska, R. (2012) · Expert Review of Medical Devices · doi:10.1586/erd.12.48 · Cited by 160
Cited by
Biofabrication of bone tissue: approaches, challenges and translation for bone regeneration
Tang, D., Tare, R. S., Yang, L.-Y., Williams, D. F., Ou, K.-L., & Oreffo, R. O. C. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.024 · Cited by 613
“If prolonged growth factor stimulation is required, physical entrapment (utilising micro- or nanospheres, or liposomes) or covalent binding (via enzymatically cleavable linkers or by chemical conjugation) is a preferable approach to ensure a more controlled or on-demand release of the growth factor or drug [122,123].”
BackgroundPoly(lactic acid) nanofibrous scaffolds for tissue engineering
Santoro, M., Shah, S. R., Walker, J. L., & Mikos, A. G. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.019 · Cited by 485
Hajiali, F., Tajbakhsh, S., & Shojaei, A. (2018) · Polymer Reviews · doi:10.1080/15583724.2017.1332640 · Cited by 267
Balmayor, E. R., Geiger, J. P., Aneja, M. K., Berezhanskyy, T., Utzinger, M., Mykhaylyk, O., Rudolph, C., & Plank, C. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.018 · Cited by 105
Yildirimer, L., & Seifalian, A. M. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.04.014 · Cited by 98
Metadata
- Authors
- Mouriño, V., Cattalini, J. P., Roether, J. A., Dubey, P., Roy, I., & Boccaccini, A. R.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2013-06-19
- Volume
- 10
- Issue
- 10
- Pages
- 1353-1365
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2044882340
- Cited by
- 105
- References
- 8
- FWCI
- 6.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Composite polymer-bioceramic scaffolds with drug delivery capability for bone tissue engineering. https://app.cochat.ai/papers/10.1517/17425247.2013.808183
- The paper
- Mouriño, V., Cattalini, J. P., Roether, J. A., Dubey, P., Roy, I., & Boccaccini, A. R. (2013). Composite polymer-bioceramic scaffolds with drug delivery capability for bone tissue engineering. Expert Opinion on Drug Delivery. https://doi.org/10.1517/17425247.2013.808183
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.